News Summary: Merck 3Q net up 2 pct, beats views

Published



REASSURING RESULTS: Drugmaker Merck posted a 2 percent increase in third-quarter profit, at $1.7 billion. That’s despite new generic competition slashing sales for top seller Singulair for asthma and allergies. It had generated $5.5 billion a year.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.